1,579 research outputs found

    Clinical Pathway for the Fontan Patient to Standardize Care

    Get PDF
    Paper approved May 2019 by the faculty of UMKC in partial fulfillment of the degree of Doctor of Nursing PracticeApproved May 2019 by faculty of UMKC in partial fulfillment of the requirements for the degree of Doctor of Nursing PracticeThe Fontan repair is the final stage of surgical palliation for the pediatric patient with a single ventricle heart. The post-operative medical management of this patient population can be variable and hospital length of stay prolonged. With the evidence-based practice movement, healthcare institutions have embraced clinical pathways as a means to standardize care and improve quality. The purpose of the retrospective quasi-experimental cohort project was to determine if the implementation of an evidenced-based clinical pathway for post-operative management of the Fontan patient at a large academic pediatric medical center in the Midwest would standardize care and decrease length of stay. Components of the clinical pathway include 1) supplemental oxygen until pleural drainage tubes are removed, 2) fluid restriction to 80% daily maintenance and a prescribed low-fat diet, 3) aggressive and standardized diuretic therapy while inpatient, and 4) central venous access. Charts were reviewed from consecutive immediate post-operative Fontan patients from 2014-2015, pre-pathway implementation, and 2017-2018, post-pathway implementation, with total sample size of 67 patients (37 pre-, 30 post-). Key outcomes measured were adherence to the pathway, length of stay, and readmissions for pleural effusion. Adherence to the pathway was nearly 100% with a statistically significant decrease in LOS from 12 to 9 days (p = .007) and no increase in readmissions (p = 0.500). Standardizing care can improve clinical outcomes for the Fontan patient population without negatively impacting quality of care, thus providing a positive benefit to the healthcare institution, industry, and patient

    Esophageal cancer in a young woman with bulimia nervosa: a case report

    Get PDF
    Adenocarcinoma of the esophagus has increased dramatically within the United States and continues to have a poor prognosis despite aggressive treatment. Identifying potential risk factors is critical for the early detection and treatment of this disease. The present case report describes a very young woman who developed adenocarcinoma of the esophagus after only a brief history of bulimia. These findings suggest that even in very young patients, bulimia may represent a risk factor for adenocarcinoma of the esophagus

    Optimization and activation of renewable durian husk for biosorption of lead (II) from a aqueous medium

    Get PDF
    Background: Biosorption of lead Pb(II) by durian husk activated carbon (DHAC) was investigated. The main aim of this work is to explore the effect of operating variables such as pH, biosorbent dose, temperature, initial metal ion concentration and contact time on the removal of Pb(II) from synthesized aqueous medium using a response surface methodology (RSM) technique. The experimentation was performed in two sets, namely set 1 and set 2. Results: For experimental set 1, pH was set to 7.0. The optimum conditions for the remaining parameters were determined to be 0.39 g DHAC dose, 60 min contact time and 100 mg L−1 of initial metal ion concentration, which yielded maximum biosorption capacity of 14.6 mg g−1. For experimental set 2, 41.27 °C, 8.95 and 99.96 mg L−1 were the optimum conditions determined for temperature, pH and initial Pb(II) concentration, respectively; which revealed a maximum adsorption capacity of 9.67 mg g−1. Characterization of the adsorbent revealed active functional groups such as hydroxyl, carboxylic, alcohol and hemicellulose. The equilibrium adsorption data obeyed the Langmuir isotherm and pseudo‐second‐order kinetic models with maximum Langmuir uptake of 36.1 mg g−1. Conclusions: The biosorbent was capable of reuse, so that the abundant durian husk could be utilized effectively for the removal of Pb(II) from polluted water

    Applied investigation of person-specific and context-specific factors on postoperative recovery and clinical outcomes of patients undergoing gastrointestinal cancer surgery: multicentre European study

    Get PDF
    INTRODUCTION: Cancer treatments have greatly advanced over the past two decades causing survival improvements and reduced complications from cancer surgery. However, the cancer diagnosis and the effects of treatment modalities pose a major risk to patients' psychological well-being. Given current interest and emerging evidence about the importance of psychological and social factors on cancer survival and coping with cancer treatments, this study will build and expand research in order to identify key modifiable psychosocial variables that contribute to better physical and mental health following gastrointestinal cancer (GIC) surgery. OBJECTIVES: To elucidate the incidence of postoperative psychiatric morbidity within 6 months following GIC surgery. To identify key measurable modifiable preoperative psychological factors that can significantly affect postoperative psychiatric morbidity in patients undergoing surgery for GIC. To clarify the changes seen in a patient's psychological well-being during their treatment pathway for GIC. METHODS AND ANALYSIS: This multicentre study has an observational longitudinal study design. In total, 1000 patients will be screened with a multicomponent psychological questionnaire at four different time points: at diagnosis, preoperatively, 1 and 6 months after surgery. Data from this questionnaire will be linked to postoperative complications including psychiatric morbidity, length of hospital stay and recovery to normal activity. ETHICS AND DISSEMINATION: NHS Health Research Authority approval was gained on (REC reference 15.LO/1847) for the completion of this study. Multiple platforms will be used for the dissemination of the research data, including international clinical and patient group presentations and publication of research outputs in a high impact clinical journal

    Simultaneous Identification of Duplications and Lateral Gene Transfers

    Full text link

    Results of surgical management of acute thromboembolic lower extremity ischemia

    Get PDF
    ObjectiveAcute lower extremity ischemia secondary to arterial thromboembolism is a common problem. Contemporary data regarding this problem are sparse. This report examines a 10-year single-center experience and describes the surgical management and outcomes observed.MethodsProcedural codes were used to identify consecutive patients treated surgically for acute lower extremity embolization from January 2002 to September 2012. Patients presenting >7 days after onset of symptoms, occlusion of grafts/stents, and cases secondary to trauma or iatrogenic injury were excluded. Data collected included demographics, medical comorbidities, presenting clinical characteristics, procedural specifics, and postoperative outcomes. Results were evaluated using descriptive statistics, product-limit survival analysis, and logistic regression multivariable modeling.ResultsThe study sample included 170 patients (47% female). Mean age was 69.1 ± 16.0 years. Of these, 82 patients (49%) had a previous history of atrial fibrillation, and four (2%) were therapeutically anticoagulated (international normalized ratio ≥2.0) at presentation. Presentation for 83% was >6 hours after symptom onset, and 9% presented with a concurrent acute stroke. Femoral artery exploration with embolectomy was the most common procedural management and was used for aortic, iliac, and infrainguinal occlusion. Ten patients (6%) required bypass for limb salvage during the initial operation. Local instillation of thrombolytic agents as an adjunct to embolectomy was used in 16%, fasciotomies were performed in 39%, and unexpected return to the operating room occurred in 24%. Ninety-day amputation above or below the knee was required during the index hospitalization in 26 patients (15%). In-hospital or 30-day mortality was 18%. Median (interquartile range) length of stay was 8 days (4, 16 days), and 36% of patients were discharged to a nursing facility. Recurrent extremity embolization occurred in 23 patients (14%) at a median interval of 1.6 months. The 5-year amputation freedom and survival estimates were 80% and 41%, respectively. Predictors of 90-day amputation included prior vascular surgery, gangrene, and fasciotomy. Predictors of 30-day mortality included age, history of coronary artery disease, prior vascular surgery, and concurrent stroke.ConclusionsDespite advances in contemporary medical care, lower extremity arterial embolization remains a condition that is associated with significant morbidity and mortality. Furthermore, the condition is resource-intensive to treat and is likely preventable (initially or in recurrence) in a substantial subset of patients

    Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas

    Get PDF
    Oesophageal and gastric adenocarcinoma share an unexplained male predominance, which would be explained by the hypothesis that oestrogens are protective in this respect. We carried out a nested case–control study of hormone replacement therapy (HRT) among 299 women with oesophageal cancer, 313 with gastric cancer, and 3191 randomly selected control women, frequency matched by age and calendar year in the General Practitioners Research Database in the United Kingdom. Data were adjusted for age, calendar year, tobacco smoking, alcohol consumption, body mass index, hysterectomy, and upper gastrointestinal disorders. Among 1 619 563 person-years of follow-up, more than 50% reduced risk of gastric adenocarcinoma was found among users of HRT compared to nonusers (odds ratio (OR), 0.48, 95% confidence interval (CI) 0.29–0.79). This inverse association appeared to be stronger for gastric noncardia (OR 0.34, 95% CI 0.14–0.78) and weaker for gastric cardia tumours (OR 0.68, 95% CI 0.23–2.01). There was no association between HRT and oesophageal adenocarcinoma (OR 1.17, 95% CI 0.41–3.32)

    Orbifold projection in supersymmetric QCD at N_f\leq N_c

    Get PDF
    Supersymmetric orbifold projection of N=1 SQCD with relatively small number of flavors (not larger than the number of colors) is considered. The purpose is to check whether orbifolding commutes with the infrared limit. On the one hand, one considers the orbifold projection of SQCD and obtains the low-energy description of the resulting theory. On the other hand, one starts with the low-energy effective theory of the original SQCD, and only then perfoms orbifolding. It is shown that at finite N_c the two low-energy theories obtained in these ways are different. However, in the case of stabilized run-away vacuum these two theories are shown to coincide in the large N_c limit. In the case of quantum modified moduli space, topological solitons carrying baryonic charges are present in the orbifolded low-energy theory. These solitons may restore the correspondence between the two theories provided that the soliton mass tends to zero in the large N_c limit.Comment: 10 pages; misprint corrected, reference adde

    Reproductive factors and oesophageal cancer in Chinese women: a case-control study

    Get PDF
    <p/> <p>Background</p> <p>Previous studies showed that sex hormone might play a role in the development of oesophageal cancer in Western countries. However, evidence from Chinese populations is still lacking.</p> <p>Methods</p> <p>We performed a hospital-based case-control study in Guangzhou, China. From June 2006 to May 2009, face-to-face interviews were conducted on 73 cases and 157 controls. Cases were Chinese females with newly diagnosed primary oesophageal cancer. Controls were hospitalized individuals without cancer and frequency matched by age groups. The interviews included questions about childbearing and menarche history, together with potential confounders. Unconditional logistic regression was used to estimate the risk of factors.</p> <p>Results</p> <p>Women who had given birth before were not at increased risk compared to childless women (adjusted OR = 1.17, 95% CI: 0.48 ~ 2.85). The risk of oesophageal cancer increased with age at first birth: the adjusted OR for women first giving birth at age 25 or later was 2.02 (95% CI: 1.01 ~ 4.04) compared with those reporting their first birth before age 22. History of spontaneous abortion was not significantly associated with increased risk (adjusted OR = 1.37, 95% CI: 0.49 ~ 3.83). No significant association was observed between menstrual variables (age at menarche, age at menopause, and years of menstruation) and risk of oesophageal cancer.</p> <p>Conclusions</p> <p>Giving birth at later age may increase the risk of oesophageal cancer in women. Further studies in Chinese populations with larger sample sizes are still needed.</p
    corecore